Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease

BACKGROUND: Dysregulated microbiota is a hallmark of end-stage liver disease (ESLD). This study aimed to elucidate the intrahepatic microbiome in hepatitis B virus (HBV)-related ESLD. METHODS: = 24), as well as 18 samples from donors. Metatranscriptomic sequencing was performed to profile liver microbiome and transcriptome. RESULTS: in ESLD displayed marked functional activation, including nutrient acquisition systems and virulence factors linked to adhesion, invasion, and toxin production. Integrated host - microbiome analysis revealed taxa-specific associations with impaired hepatic metabolic, immune, and structural integrity. CONCLUSION: This study delineates the compositional and functional reprogramming of the intrahepatic microbiome in patients with ESLD and its coupling with liver metabolic, immune, and structural pathways. These findings suggest the intrahepatic microbiome as a promising therapeutic target for ESLD.

Authors

Institutions

Publication Details

Journal
Virulence
Published
2026-04-27
DOI
https://doi.org/10.1080/21505594.2026.2665492
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease

Jiyang Chen, Chanyuan Ye, Yida Yang, Ziqing Deng et al.
Virulence
Gut microbiota and health
article

Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease

Jiyang Chen, Chanyuan Ye, Yida Yang, Ziqing Deng, Tianzhu Liang, Yan Lv, Sisi Yang, Zhou Yani, Biao Li, Xi Zhang, Y Shi, Leiming Chen, Hai Chen, Siqi Sun, Ying Nie, Yingfeng Lu, X Xu, Na Pei, Zelu Meng, Hongyu Jia, Guodong Yu, Xin Zheng, Yining Zhang, Zhiwei Li, Guoqiang Cao, Xia Yu, Huilan Tu, Yiwei Liu
article en

Abstract

BACKGROUND: Dysregulated microbiota is a hallmark of end-stage liver disease (ESLD). This study aimed to elucidate the intrahepatic microbiome in hepatitis B virus (HBV)-related ESLD. METHODS: = 24), as well as 18 samples from donors. Metatranscriptomic sequencing was performed to profile liver microbiome and transcriptome. RESULTS: in ESLD displayed marked functional activation, including nutrient acquisition systems and virulence factors linked to adhesion, invasion, and toxin production. Integrated host - microbiome analysis revealed taxa-specific associations with impaired hepatic metabolic, immune, and structural integrity. CONCLUSION: This study delineates the compositional and functional reprogramming of the intrahepatic microbiome in patients with ESLD and its coupling with liver metabolic, immune, and structural pathways. These findings suggest the intrahepatic microbiome as a promising therapeutic target for ESLD.

VirulenceVol. 17(1)
Botswana Geoscience Institute (BW), First Affiliated Hospital Zhejiang University (CN), BGI Research (CN), Zhejiang University (CN)
National Natural Science Foundation of China, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Key Research and Development Program of China
Openalex Percentile: Top 17%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.